Prescription drug coverage is part of your health plan. How it works varies a lot by plan type, and the costs, formularies, and incentives all differ. Employers and employees both need to understand the mechanics and the pain points. A modern approach can turn prescriptions from a cost center into a real advantage.
The Basics: How Drug Coverage Fits Into Health Benefits
Your health plan sets a drug formulary, a list of covered medications, often organized into tiers. Generic drugs (Tier 1) have the lowest copays; brand-name and specialty drugs (Tiers 3-5) cost more. The plan also sets deductibles, copays, and out-of-pocket maximums for prescriptions. A Pharmacy Benefit Manager (PBM) processes claims, negotiates rebates from drug companies, and manages prior authorizations. Many PBMs also hide their pricing games. Spread pricing, for example, lets a PBM charge the plan more than it pays the pharmacy and keep the difference, inflating employer drug spend without the employer seeing it.
Employees pay their share through copays, coinsurance, or deductibles. A short list of preventive medications, such as statins for adults at risk of heart disease and tobacco cessation drugs, carries no cost sharing under ACA rules. That benefit is real, but high copays on other maintenance drugs still push many people to skip refills and get worse.
Common Challenges With Traditional Prescription Drug Coverage
The traditional model has a few big problems:
- Opaque pricing: Most employers don't know the real net cost of a drug. PBMs pocket the spread between what they bill the plan and what they pay the pharmacy.
- Misaligned incentives: PBMs favor high-rebate drugs, not necessarily the best or cheapest. That raises overall spend.
- Low adherence: High copays, prior auths, and forgetfulness make people skip fills. That leads to ER visits and hospitalizations.
- Waste: Up to a quarter of healthcare spending is waste, according to a 2019 JAMA analysis. A big chunk comes from mismanaged meds: missed refills, non-adherence, and picking brand over generic.
FTC Enforcement Against the Big Three PBMs
That opacity is now under direct regulatory pressure. In September 2024, the Federal Trade Commission sued the three largest PBMs, Caremark Rx, Express Scripts, and OptumRx, along with their group purchasing organizations, alleging anticompetitive rebate practices that inflated insulin list prices. The FTC settled with Express Scripts in February 2026 and with Caremark Rx in July 2026, both on terms requiring more transparency and lower patient out-of-pocket costs. Rebate-driven formulary design and hidden margins are losing their cover.
For employers, that makes transparency a procurement requirement rather than a preference. Plans that rely on spread pricing and rebate opacity carry regulatory risk along with cost risk. A transparent pharmacy model removes the question before a regulator or an auditor raises it.
How an Integrated Approach Improves Drug Coverage
Modern benefits systems, like WellthCare™, reimagine prescription drug coverage as part of a Health-to-Wealth™ operating system. Rather than treating pharmacy as a standalone PBM function, they align incentives so that better drug adherence saves money for both employers and employees. This integrated pharmacy sits alongside the primary health plan and gets used first. It adds to existing ACA-compliant employer coverage instead of replacing it.
Mechanisms of an Integrated Approach
- Transparent pricing: Ditch the opaque PBM. Use a plan-designated pharmacy with transparent pricing and no spread. Employers and employees see the real cost of each drug.
- Personalized AI reminders: The system tracks each employee's care plan, including preventive actions, labs, and scans. A branded AI concierge sends timely alerts to take meds, refill, or switch to a cheaper generic. Those reminders help people stay on their medications.
- Automatic wealth building: Every time an employee completes a preventive action, such as a lab or filling a maintenance script, the system credits reward dollars to their WellthCare Store™ account, and program savings fund an automatic retirement contribution. Adherence pays. WellthCare makes that promise real by rewarding every verified preventive action with spendable Store dollars and automatic retirement contributions. Healthcare that pays you back.
- Self-funded savings: For self-funded plans (WellthCare Complete™), the integrated pharmacy typically cuts drug costs 20-40% versus commercial plans. Add better adherence, and savings compound.
Real-World Impact: What This Means for Employers and Employees
When drug coverage works this way, the benefits pile up:
- Employers see lower drug spend by cutting out PBM spread while adherence goes up, a rare win-win.
- Employees get $0 copays on the preventive drugs the ACA covers and earn Store dollars plus retirement contributions just for staying adherent.
- Retirement wealth grows automatically from what employers save. The dollars that once fed PBM spread become automatic retirement contributions instead.
Choosing the Right Prescription Drug Model
When evaluating health plans, ask yourself these four questions:
- Is your PBM transparent? Ask for a breakdown of fees, rebates, and spread pricing. If they won't share, that's a red flag.
- Does your plan integrate pharmacy with preventive care? Look for systems that tie adherence to rewards instead of only processing claims.
- Can employees earn wealth from healthy behavior? The next generation of benefits uses pharmacy as a lever to build savings while cutting costs.
- What happens at age 65? Medicare solutions that keep retirees in the same system, with pharmacy, Store, and retirement continuity, reduce risk and improve outcomes.
Prescription drug coverage is about more than paying for pills. In a well-designed system, it becomes the engine for lower costs, better health, and automatic wealth growth, delivered with simplicity and compliance. That is the new standard for healthcare benefits.
This article is for general information only and is not legal, tax, or medical advice. Employers should consult their own advisors.